Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81. uri icon

Overview

publication date

  • January 1, 2009

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2008.09.037

PubMed ID

  • 20050019

Additional Document Info

volume

  • 55

issue

  • 1